Celiac Disease Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Celiac Disease Industry In 2025?

The celiac disease market size has seen significant expansion in recent years. It is anticipated to increase from $0.71 billion in 2024 to $0.78 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.4%. The factors contributing to this growth in previous periods include the escalating prevalence of celiac disease, heightened public knowledge of gluten-related conditions, increased financial support for autoimmune disease research, a rise in occurrences of food allergies and sensitivities, and a greater emphasis on health among consumers.

The celiac disease market is projected to experience substantial expansion over the upcoming years. This market is set to reach a valuation of $1.15 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. The anticipated growth during this period is driven by factors such as the increasing call for personalized medicine, the broadening of healthcare infrastructure, a greater need for nutritional counseling services, an increase in pediatric diagnosis rates, and an emphasis on early life screening and preventative measures. Key developments anticipated in the forecast period encompass the wider availability of diagnostic testing, progress in genetic testing technologies, enhanced screening protocols within primary care, technological breakthroughs in ELISA and serological testing, and the increasing uptake of non-invasive diagnostic methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

What Are The Top Growth Drivers Impacting The Celiac Disease Market Outlook?

The celiac disease market is anticipated to expand due to the advancement of personalized medicine. This healthcare method tailors treatments to an individual’s unique genetic makeup, environmental factors, and lifestyle choices. The demand for personalized medicine is increasing, driven by wider access to genetic testing, which allows for more precise diagnoses and therapies specifically designed for each patient. In the context of celiac disease treatment, personalized medicine facilitates the exact identification of genetic markers and distinct immune responses, resulting in more focused and efficient management plans for every patient. As an illustration, the Personalized Medicine Coalition, a US-based nonprofit, reported in February 2024 that the FDA cleared 16 personalized therapies for rare diseases in 2023, representing an increase from the 6 approved in 2022. Consequently, the expansion of personalized medicine is set to propel the celiac disease market forward.

What Are The Key Segments In The Celiac Disease Market?

The celiac disease market covered in this report is segmented –

1) By Treatment: Infliximab, Larazotide Acetate, Gluten Free Diet, Other Treatments

2) By Route Of Administration: Oral, Parenteral

3) By End Users: Hospitals, Homecare, Other End-Users

Subsegments:

1) By Infliximab: Biosimilar Infliximab, Branded Infliximab, Intravenous Administration, Hospital-Based Usage, Off-Label Use In Refractory Celiac Disease,

2) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

3) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

4) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

Which Market Trends Are Creating New Opportunities In The Celiac Disease Industry?

Leading companies within the celiac disease market are prioritizing the creation of advanced interventions, such as anti-interleukin-15 (IL-15) antibodies, to mitigate tissue damage by reining in excessive immune cell activity. These anti-interleukin-15 (IL-15) antibodies are specialized proteins designed to inhibit the function of the IL-15 cytokine, thereby assisting in the regulation of immune system activity and inflammation. For example, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, publicized that the U.S. Food and Drug Administration had granted Fast Track status to TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. This particular investigational monoclonal antibody is being developed for individuals with celiac disease who continue to follow a gluten-free diet. Its mode of action involves blocking interleukin-15 (IL-15), a molecule instrumental in initiating the immune response that results in intestinal harm for celiac patients. The therapy is presently undergoing a Phase 2a clinical trial to assess both its safety and effectiveness.

Who Are The Core Companies Influencing The Celiac Disease Market Landscape?

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

How Is Celiac Disease Market Demand Varying Across Different Regions?

North America was the largest region in the celiac disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Celiac Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24497&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Market 2025, By The Business Research Company

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Rare Inflammatory Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795